MORGESE, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.734
EU - Europa 3.073
AS - Asia 2.386
SA - Sud America 308
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 9.565
Nazione #
US - Stati Uniti d'America 3.684
SG - Singapore 928
CN - Cina 832
IE - Irlanda 712
UA - Ucraina 453
RU - Federazione Russa 435
IT - Italia 348
SE - Svezia 340
DE - Germania 262
BR - Brasile 253
FR - Francia 198
HK - Hong Kong 152
FI - Finlandia 147
VN - Vietnam 124
IN - India 112
TR - Turchia 87
GB - Regno Unito 59
BD - Bangladesh 29
AR - Argentina 22
CA - Canada 22
ID - Indonesia 21
PL - Polonia 19
IQ - Iraq 18
CZ - Repubblica Ceca 17
BE - Belgio 16
NL - Olanda 14
JP - Giappone 13
PK - Pakistan 13
MX - Messico 12
TN - Tunisia 11
ZA - Sudafrica 11
RO - Romania 10
AT - Austria 9
VE - Venezuela 9
ES - Italia 8
EG - Egitto 7
EC - Ecuador 6
EU - Europa 6
KR - Corea 6
SC - Seychelles 6
UZ - Uzbekistan 6
CL - Cile 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
PY - Paraguay 5
SA - Arabia Saudita 5
CO - Colombia 4
IL - Israele 4
JO - Giordania 4
MA - Marocco 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
JM - Giamaica 3
LT - Lituania 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
SN - Senegal 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
RS - Serbia 1
SO - Somalia 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 9.563
Città #
Dublin 712
San Jose 482
Singapore 479
Chandler 453
Ashburn 337
Jacksonville 311
Nyköping 235
Dearborn 221
Beijing 186
Dallas 166
Nanjing 154
Hong Kong 151
Munich 143
Santa Clara 108
The Dalles 106
New York 97
Helsinki 88
Lauterbourg 83
Princeton 77
Wilmington 74
Ann Arbor 61
Moscow 57
Los Angeles 53
San Mateo 51
Foggia 49
Nanchang 46
Boardman 40
Ho Chi Minh City 40
Shenyang 37
Bari 35
Hanoi 33
Des Moines 30
Pune 29
Hebei 28
Tianjin 26
Woodbridge 26
Kunming 23
Seattle 23
Jinan 20
Rome 19
Changsha 18
Frankfurt am Main 18
Hangzhou 18
Jiaxing 18
São Paulo 17
Warsaw 17
Guangzhou 16
Manfredonia 15
Brussels 14
Chicago 13
Ningbo 13
Shanghai 13
Zhengzhou 13
Falkenstein 12
Tokyo 12
Brno 11
Columbus 11
Milan 11
Belo Horizonte 10
London 10
Naples 10
Washington 10
Wuhan 10
Atlanta 9
Bologna 9
Council Bluffs 9
Düsseldorf 9
Nuremberg 9
Rio de Janeiro 9
Shenzhen 9
Dhaka 8
Lanzhou 8
Orange 8
Orem 8
San Francisco 8
Brooklyn 7
Chengdu 7
Chennai 7
Hilden 7
Jakarta 7
Johannesburg 7
Stockholm 7
Turku 7
Auburn Hills 6
Campinas 6
Mumbai 6
Redwood City 6
Stevenage 6
Tashkent 6
Baghdad 5
Biên Hòa 5
Boston 5
Can Tho 5
Hillsboro 5
Montreal 5
Paris 5
Phoenix 5
Amsterdam 4
Assago 4
Buffalo 4
Totale 5.946
Nome #
Visceral fat dysfunctions in the rat social isolation model of psychosis 259
Antidepressant drugs for beta amyloid-induced depression: A new standpoint? 201
N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype 173
Chlorella sorokiniana extract improves short-term memory in rats 169
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 163
Cognitive deficits are paralleled by increased emotionality and altered glutamatergic and monoaminergic neurotransmission in rats perinatally exposed to a moderate dose of delta9-tetrahydrocannabinol 157
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 156
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 156
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 153
Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? 153
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 151
Chronic nandrolone administration induces dysfunction of the reward pathway in rats. 148
Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats 148
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 146
Influence of nitric oxide on cortical dopaminergic system in an animal model of Alzheimer’s disease: an in vivo study 145
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 143
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 141
Carvacrol: from ancient flavoring to neuromodulatory agent. 139
N-3 PUFA Prevent Oxidative Stress in a Rat Model of Beta-Amyloid-Induced Toxicity 135
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 134
Effects of anabolic-androgens on brain reward function 134
Effects of n-3 PUFA enriched and n-3 PUFA deficient diets in naïve and Aβ-treated female rats 132
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 130
Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice 130
Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis 129
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid 126
Ketamine administration in early postnatal life as a tool for mimicking Autism Spectrum Disorders core symptoms 125
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 124
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 123
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 123
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1 123
Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2 123
Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds? 121
The NADPH oxidase NOX2 as a novel biomarker for suicidality: Evidence from human post mortem brain samples 121
Depressive-like phenotype evoked by lifelong nutritional omega-3 deficiency in female rats: Crosstalk among kynurenine, Toll-like receptors and amyloid beta oligomers 119
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats 116
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 116
Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats 115
Extraction, Characterization and In Vivo Neuromodulatory Activity of Phytosterols from Microalga Dunaliella Tertiolecta. 115
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 113
Postnatal Antioxidant and Anti-inflammatory Treatments Prevent Early Ketamine-Induced Cortical Dysfunctions in Adult Mice 113
Precision Medicine in Alzheimer’s Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity 113
Neurochemical differences in two rat strains exposed to social isolation rearing 109
The Visible Burrow System: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains 108
Sub-chronic celecoxib prevents soluble beta amyloid-induced depressive-like behaviour in rats 108
Early celastrol administration prevents ketamine-induced psychotic-like behavioral dysfunctions, oxidative stress and IL-10 reduction in the cerebellum of adult mice 108
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 107
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 105
Emerging role of amyloid beta in stress response: Implication for depression and diabetes 105
Improvement of renal function in epidermolysis bullosa patients after gluten free diet: two cases 104
Modulatory Activity of Soluble Beta Amyloid on Hpa Axis Function in Rats. 102
Sublingual AKBA Exerts Antidepressant Effects in the Aβ-Treated Mouse Model 102
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 101
Social isolation triggers oxidative status and impairs systemic and hepatic insulin sensitivity in normoglycemic rats 101
Increased iNOS and nitrosative stress in dopaminergic neurons of MDMA-exposed rats 99
N-3 PUFA supplementation in adulthood modulates diet-induced depressive-like phenotype in female rats 98
Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism 97
Solubile beta amyloid- induced alterations: neurochemical, behavioural and biochemical evidence in rats 97
The cannabinoid agonist WIN55212,2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats 97
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 95
Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress. 93
SOLUBLE BETA AMYLOID-INDUCED ALTERATIONS: NEUROCHEMICAL, BEHAVIOURAL AND BIOCHEMICAL EVIDENCE IN RATS 92
Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa 92
SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA Vaccination 91
Special Issue "Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders" 91
Early life and oxidative stress in psychiatric disorders: what can we learn from animal models? 90
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 89
Lifelong exposure to n-3 PUFA deficiency leads to anxiety-like profile in male and female adolescent rats: Impact on spleen-brain axis 84
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats 84
ESTRUS CYCLE IN FEMALE RATS AFFECTS THE NEUROCHEMICAL AND NEUROBEHAVIOURAL PROFILE OF CARVACROL 83
Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes 83
Social isolation from early life induces anxiety-like behaviors in adult rats: Relation to neuroendocrine and neurochemical dysfunctions 79
ESTROUS CYCLE IN FEMALE RATS INFLUENCES THE NEUROCHEMICAL AND NEUROBEHAVIOURAL EFFECTS OF CARVACROL 78
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 77
Sex differences in the BTBR idiopathic mouse model of autism spectrum disorders: Behavioural and redox-related hippocampal alterations 76
Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour 74
The therapeutic potential of celastrol in central nervous system disorders: Highlights from in vitro and in vivo approaches 74
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids 72
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target 69
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 68
Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice 65
Monoaminergic system modulation in depression and Alzheimer's disease: A new standpoint? 62
Increased stress vulnerability in the offspring of socially isolated rats: Behavioural, neurochemical and redox dysfunctions 61
Analysis of Adherence to anti-PCSK9 Antibody Therapy among Patients from Italy 61
Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice 61
Palmitoylethanolamide counteracts brain fog improving depressive-like behaviour in obese mice: Possible role of synaptic plasticity and neurogenesis 58
Drug testing after use: what insights can be gained from a harm reduction perspective on visitors of the drugs information and monitoring system (DIMS) in the Netherlands? 53
Effects of preconceptional social isolation on risk-taking behaviour and levels of neurochemical, neuroendocrine and neuroinflammatory markers in male offspring 42
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 42
Radiosynthesis and whole-body distribution in mice of a 18F-labeled azepino[4,3-b]indole-1-one derivative with multimodal activity for the treatment of Alzheimer's disease 33
Totale 9.874
Categoria #
all - tutte 50.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 87 2 5
2021/2022480 56 11 16 11 22 13 17 38 68 76 16 136
2022/20231.843 156 97 70 123 89 171 17 175 851 11 41 42
2023/2024535 41 17 13 16 43 181 62 28 6 15 6 107
2024/20251.802 60 38 49 45 93 259 191 118 458 142 191 158
2025/20262.671 199 237 392 321 160 138 593 330 181 120 0 0
Totale 9.874